The correlation between elevated XIAP levels and clinical outcome, however, is not straightforward since its overexpression correlates with disease severity in acute myeloid leukaemia but not in lung cancer or prostate cancer [17,18]. The gene discussed is XIAP; the disease is acute myeloid leukemia.